Edition:
United States

Proteon Therapeutics Inc (PRTO.OQ)

PRTO.OQ on NASDAQ Stock Exchange Global Market

2.35USD
17 Aug 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.35
Open
$2.35
Day's High
$2.40
Day's Low
$2.35
Volume
3,828
Avg. Vol
4,541
52-wk High
$2.90
52-wk Low
$1.30

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.276
Mar '18 0.00 -0.344
FY 2017 Dec '17 0.00 -0.315
Sep '17 0.00 -1.084
Jun '17 0.00 -0.326
Mar '17 0.00 -0.391
FY 2016 Dec '16 0.00 -0.420
Sep '16 0.00 -0.429
Jun '16 0.00 -0.477
Mar '16 0.00 -0.397
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 3 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 3 0.00 0.00 0.00 0.00
Year Ending Dec-18 4 0.00 0.00 0.00 0.00
Year Ending Dec-19 5 0.50 2.50 0.00 8.72
Earnings (per share)
Quarter Ending Sep-18 4 -0.32 -0.30 -0.37 -0.40
Quarter Ending Dec-18 4 -0.33 -0.31 -0.37 -0.36
Year Ending Dec-18 4 -1.27 -1.24 -1.36 -1.52
Year Ending Dec-19 6 -1.12 -0.77 -1.60 -1.01
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 99.36 30.45
P/E High - Last 5 Yrs. -- 272.05 47.36
P/E Low - Last 5 Yrs. -- 95.21 24.74
Beta 1.40 0.78 0.84
Price to Sales (TTM) -- 126.22 5.98
Price to Book (MRQ) 10.38 13.00 3.69
Price to Tangible Book (MRQ) 1.66 22.28 5.63
Price to Cash Flow (TTM) -- 64.21 20.97
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.37 1.78
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.47 -5.93
Payout Ratio(TTM) -- 6.14 46.55

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 158.89 7.18
Sales (TTM) vs TTM 1 Yr. Ago -- 91.20 12.05
Sales - 5 Yr. Growth Rate -- 24.34 7.61
EPS (MRQ) vs Qtr. 1 Yr. Ago 15.30 74.27 23.85
EPS (TTM) vs TTM 1 Yr. Ago -29.06 -- --
EPS - 5 Yr. Growth Rate -- 23.23 7.52
Capital Spending - 5 Yr. Growth Rate -12.18 36.95 8.06

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.73 2.50
Current Ratio (MRQ) 12.33 5.42 3.53
LT Debt to Equity (MRQ) 0.00 19.75 11.27
Total Debt to Equity (MRQ) 0.00 23.48 14.23
Interest Coverage (TTM) -- -186.89 31.77

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 57.13 55.23
Gross Margin - 5 Yr. Avg. -- 52.64 53.33
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -3,197.22 -189.34 15.82
Operating Margin (TTM) -- -673.76 3.86
Operating Margin - 5 Yr. Avg. -3,210.28 -202.74 10.95
Pre-Tax Margin (TTM) -- -665.74 4.16
Pre-Tax Margin - 5 Yr. Avg. -3,090.94 -203.67 11.12
Net Profit Margin (TTM) -- -655.99 0.98
Net Profit Margin - 5 Yr. Avg. -3,090.94 -201.27 7.47
Effective Tax Rate (TTM) -- 12.18 20.36
Effective Tax Rate - 5 Yr. Avg. -- 18.69 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 5,071,848 718,909,906
Net Income/Employee (TTM) -- -6,208,777 83,624,743
Receivable Turnover (TTM) -- 6.39 5.38
Inventory Turnover (TTM) -- 2.25 3.51
Asset Turnover (TTM) 0.00 0.42 0.83

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -93.74 1.88 10.04
Return on Assets - 5 Yr. Avg. -40.07 2.31 10.94
Return on Investment (TTM) -104.57 2.89 12.63
Return on Investment - 5 Yr. Avg. -45.37 1.68 14.14
Return on Equity (TTM) -211.75 1.65 14.82
Return on Equity - 5 Yr. Avg. -234.41 -6.94 15.50
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -23.38 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Proteon Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 67.91%
# of Holders: 32
Total Shares Held: 12,037,549
3 Mo. Net Change: 77,700
# New Positions: 3
# Closed Positions: 6
# Increased Positions: 9
# Reduced Positions: 8
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.